Artos was founded by Josh Kim, Varun Patel in 2023.

Who are Artos's investors?

Artos's investors include Y Combinator, Horizon, Maiora Rebel Ventures, MyAsiaVC, Pioneer, Antler, New Order, Phoenix Fund and 1 more.

Where is Artos headquartered?

Artos is headquartered in San Francisco, US.

Artos

YC W24

San Francisco, US · Founded 2023 · 7 employees · Hiring · 9 known investors

Find your way into Artos

Paths you didn't know you had: your email and LinkedIn already hold routes to the Artos team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Artos provides AI-powered software tools for Chemistry, Manufacturing, and Controls (CMC) teams in the pharmaceutical industry to draft, manage, and quality-check regulatory documentation. The platform uses specialized AI systems designed to handle dense tabular data and non-standard formats common in regulatory Module 3 documents.

Also known as Talos

AI & Machine Learning Biotech Enterprise Software Medical DevicesUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W24)

Artos was founded in 2023 by Josh Kim and Varun Patel.

Josh Kim CEOHe previously directed AI initiatives at the University of Chicago Medicine focused on clinical trial and medical device applications, and held roles in commercial and regulatory strategy at biotech companies. He studied Economics at the University of Chicago.

Varun Patel CTOVarun Patel is a co-founder and CTO at Artos with a background in molecular engineering (University of Chicago) and translational medicine (UCSF/UC Berkeley). He previously worked as a software engineer developing machine learning applications for healthcare, including mobile tools for dementia caregivers and insurance infrastructure improvements.

John FabelloPrincipal Recruiter

Investors · 9

Y Combinator✓ confirmed by ArtosSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Horizonlisted by HorizonMiami Beach

How we know: Y Combinator's founder network · Not right? Tell us

Maiora Rebel Ventureslisted by Maiora Rebel Ventures

How we know: Y Combinator's founder network · Not right? Tell us

MyAsiaVClisted by MyAsiaVCSeattlevia Aabhas Khanna · inferred

How we know: Y Combinator's founder network · Not right? Tell us

Pioneerlisted by PioneerToronto, Ontario

How we know: Y Combinator's founder network · pioneerfund.vc · open dataset · 5k.vc investor directory · Not right? Tell us

AntlerreportedSingapore · $125K

How we know: funding news · Not right? Tell us

New Orderreported

How we know: Y Combinator's founder network · Not right? Tell us

Phoenix FundreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Socii CapitalreportedSan Francisco

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Images

Related companies · 6

IktosSpaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials. It serves chemists and drug discovery teams seeking to accelerate research through rapid, customizable synthesis planning.

Altos LabsAltos Labs develops computational and scientific approaches to reverse disease through breakthrough medicines, operating research institutes focused on cell health, computation, and drug discovery.

ACTOActo provides a mobile app platform for field-based sales teams in regulated industries to deliver training, coaching, and presentations with approved content and messaging. The solution includes keyword search, knowledge tracking via surveys, and push notification alerts for content updates.

AetosAetos Imaging provides a visual management software built on digital scans of a customer's physical facility, used to manage, maintain, and train around building operations and assets. It serves energy and utilities, manufacturing, and other industrial and built-environment organizations.

Artios PharmaArtios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers. The company focuses on advancing DDR-based therapies through strategic partnerships.

Areto LabsAreto Labs offers a responsible AI platform that combines human judgment with AI to detect and filter harmful online content such as hate speech and technology-facilitated gender-based violence, helping global brands and public figures build safer digital communities. The women-owned Canadian company serves organizations across sectors including politics, sport, and media.

Companies working in the same space as Artos.

Legal entities · 1

corporate structure

Artos, Inc.

In the news

Artos Funding | Complete Analysis | Extruct AIextruct.ai · Mar 2024

Artos - Turning science into regulatory submissionsycombinator.com · Jan 2024

Frequently asked questions

What does Artos do?: Artos provides AI-powered software tools for Chemistry, Manufacturing, and Controls (CMC) teams in the pharmaceutical industry to draft, manage, and quality-check regulatory documentation. The platform uses specialized AI systems designed to handle dense tabular data and non-standard formats common in regulatory Module 3 documents.
Who founded Artos?: Artos was founded by Josh Kim, Varun Patel in 2023.
Who are Artos's investors?: Artos's investors include Y Combinator, Horizon, Maiora Rebel Ventures, MyAsiaVC, Pioneer, Antler, New Order, Phoenix Fund and 1 more.
Where is Artos headquartered?: Artos is headquartered in San Francisco, US.